Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Apostolos Papachristos

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancer Chemotherapy and Pharmacology|April 1, 2022
Lurbinectedin-induced thrombocytopenia: the role of body surface areaApostolos Papachristos, Mark J Ratain
Cancer Chemotherapy and Pharmacology|August 24, 2015
Personalizing chemotherapy dosing using pharmacological methodsJai N Patel, Apostolos Papachristos
Journal of Personalized Medicine|August 8, 2020
Pharmacogenomics, Pharmacokinetics and Circulating Proteins as Biomarkers for Bevacizumab Treatment Optimization in Patients with Cancer: A ReviewApostolos Papachristos, Gregory B Sivolapenko
Clinical Pharmacology and Therapeutics|November 4, 2020
Accelerated Approval of Anticancer Drugs: Lessons Learned From the Example of OlaratumabApostolos Papachristos, Mark J Ratain
The Oncologist|April 10, 2020
Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal CancerApostolos Papachristos, Polychronis Kemos, Haralabos Kalofonos, et al.
International Journal of Molecular Sciences|May 30, 2020
Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal CancerApostolos Papachristos, Eleni Karatza, Haralabos Kalofonos, et al.
The Oncologist|October 12, 2020
In ReplyApostolos Papachristos, Polychronis Kemos, Haralabos Kalofonos, et al.
Drug Delivery|January 28, 2015
Antibody-drug conjugates: a mini-review. The synopsis of two approved medicinesApostolos Papachristos, Natassa Pippa, Costas Demetzos, et al.
Population Studies|February 15, 2022
Quantifying self-rated ageGeorgia Verropoulou, Apostolos Papachristos, George B Ploubidis, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 19, 2022
Machine learning-guided covariate selection for time-to-event models developed from a small sample of real-world patients receiving bevacizumab treatmentEleni Karatza, Apostolos Papachristos, Gregory B Sivolapenko, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancer Chemotherapy and Pharmacology|April 1, 2022
Lurbinectedin-induced thrombocytopenia: the role of body surface areaApostolos Papachristos, Mark J Ratain
Cancer Chemotherapy and Pharmacology|August 24, 2015
Personalizing chemotherapy dosing using pharmacological methodsJai N Patel, Apostolos Papachristos
Journal of Personalized Medicine|August 8, 2020
Pharmacogenomics, Pharmacokinetics and Circulating Proteins as Biomarkers for Bevacizumab Treatment Optimization in Patients with Cancer: A ReviewApostolos Papachristos, Gregory B Sivolapenko
Clinical Pharmacology and Therapeutics|November 4, 2020
Accelerated Approval of Anticancer Drugs: Lessons Learned From the Example of OlaratumabApostolos Papachristos, Mark J Ratain
The Oncologist|April 10, 2020
Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal CancerApostolos Papachristos, Polychronis Kemos, Haralabos Kalofonos, et al.
International Journal of Molecular Sciences|May 30, 2020
Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal CancerApostolos Papachristos, Eleni Karatza, Haralabos Kalofonos, et al.
The Oncologist|October 12, 2020
In ReplyApostolos Papachristos, Polychronis Kemos, Haralabos Kalofonos, et al.
Drug Delivery|January 28, 2015
Antibody-drug conjugates: a mini-review. The synopsis of two approved medicinesApostolos Papachristos, Natassa Pippa, Costas Demetzos, et al.
Population Studies|February 15, 2022
Quantifying self-rated ageGeorgia Verropoulou, Apostolos Papachristos, George B Ploubidis, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 19, 2022
Machine learning-guided covariate selection for time-to-event models developed from a small sample of real-world patients receiving bevacizumab treatmentEleni Karatza, Apostolos Papachristos, Gregory B Sivolapenko, et al.
Pageof 2